Related Experiment Video
Updated: May 11, 2026

Measurement of the Rheology of Crude Oil in Equilibrium with CO2 at Reservoir Conditions
Published on: June 6, 2017
Role of Vitamin D Levels in COVID-19 Disease Severity: A Multicenter Retrospective Study from Qatar
Insights
Vitamin D deficiency is common in hospitalized COVID-19 patients and linked to longer ICU stays. Suboptimal vitamin D levels may increase COVID-19 severity and intensive care unit (ICU) length of stay.
Area of Science:
- Infectious Diseases
- Endocrinology
- Critical Care Medicine
Background:
- Vitamin D (VD) status relationship with COVID-19 severity remains unclear in hospitalized patients.
- Investigating VD's impact on COVID-19 severity and related health factors in Qatar.
Purpose of the Study:
- To determine the association between vitamin D status and COVID-19 severity.
- To examine the effect of vitamin D on factors influencing COVID-19 outcomes.
Main Methods:
- Retrospective, cross-sectional, multicenter study (March 2020 - May 2021) at Hamad Medical Corporation, Qatar.
- COVID-19 severity assessed by neutrophil-lymphocyte ratio (NLR); VD deficiency defined as <20 ng/mL.
- Demographic, laboratory, comorbidity, and clinical outcome data analyzed using SPSS v22.
Main Results:
- Vitamin D deficiency was prevalent (68.6%) among studied patients.
- Patients with VD deficiency had significantly longer ICU stays (19.7 days) compared to those with normal VD status (11.2 days; p=0.04).
- A trend of higher NLR with lower VD levels was observed; no significant difference in IL-6 levels between VD groups.
Conclusions:
- Vitamin D status is linked to COVID-19 severity in hospitalized patients.
- Suboptimal VD levels may be associated with increased ICU length of stay.
- Vitamin D status appears to have a minor impact on the pro-inflammatory state in COVID-19.
Abstract:
<b>Background and Objective:</b> Up to now, evidence remains inconclusive about how vitamin D (VD) status relates to the severity of COVID-19 among hospitalized patients. The present study aims to explore the impact of VD status on the severity of COVID-19 among hospitalized patients in Qatar and examine its effects on health factors related to the disease. <b>Materials and Methods:</b> A retrospective, cross-sectional, multicenter study was conducted at Hamad Medical Corporation in Qatar from March, 2020 to May, 2021. Demographics, laboratory values, comorbidities, clinical outcomes and some inflammatory markers were retrieved from the hospital's system. The severity of COVID-19 disease was determined by an elevated neutrophil-lymphocyte ratio (NLR). A patient with VD levels less than 20 ng/mL was considered deficient. Data were analyzed using SPSS v22, with significance set at p<0.05, employing Mann-Whitney, Chi-squared and correlation tests as appropriate. <b>Results:</b> The VD deficiency was common (68.6%), with longer ICU stays observed in deficient patients compared to those with normal VD status (19.7 vs. 11.2; p = 0.04). There was a trend of higher NLR with lower VD levels. No significant difference in interleukin-6 levels was found between the deficient and sufficient VD groups (60.6±64.1 vs. 41.2±45.2 pg/mL; p = 0.472). <b>Conclusion:</b> This study highlights the link between VD status and COVID-19 disease severity. The findings suggest that suboptimal levels of VD in COVID-19 patients may be potentially associated with increased length of stay in the ICU and have a minor impact on the pro-inflammatory state.
More Related Videos
10:12Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
10:31Robust Differentiation of Human iPSCs into a Pure Population of Adipocytes to Study Adipocyte-Associated Disorders
Published on: February 9, 2022
Related Concept Videos
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamins
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Multiple Sclerosis l: Introduction